tiprankstipranks
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market

CSPC Pharmaceutical Group (CHJTF) Income Statement

Compare
21 Followers

CSPC Pharmaceutical Group Income Statement

Last quarter (Q2 2024), CSPC Pharmaceutical Group's total revenue was ¥16.28B, an increase of 1.18% from the same quarter last year. In Q2, CSPC Pharmaceutical Group's net income was ¥3.02B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 34.60B¥ 31.59B¥ 33.59B¥ 28.03B¥ 25.06B
Gross Profit
¥ 24.40B¥ 22.73B¥ 25.47B¥ 21.00B¥ 18.04B
Operating Expenses
¥ 16.72B¥ 15.80B¥ 17.95B¥ 14.89B¥ 13.00B
Depreciation and Amortization
¥ 1.12B¥ 1.07B¥ 1.04B¥ 906.92M¥ 784.21M
EBITDA
¥ 8.53B¥ 7.60B¥ 9.28B¥ 8.09B¥ 5.35B
Operating Income
¥ 7.68B¥ 6.93B¥ 7.53B¥ 6.11B¥ 5.05B
Other Income/Expenses
¥ -290.75M¥ 827.27M¥ 562.11M¥ 672.74M¥ 579.27M
Pretax Income
¥ 7.39B¥ 7.76B¥ 8.23B¥ 7.17B¥ 5.18B
Net Income
¥ 5.87B¥ 5.35B¥ 5.61B¥ 5.16B¥ 4.21B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 0.55¥ 0.52¥ 0.57¥ 0.49¥ 0.35
Diluted EPS
¥ 0.55¥ 0.52¥ 0.57¥ 0.49¥ 0.35
Weighted Average Shares Outstanding
11.87B 11.92B 11.95B 11.95B 11.95B
Weighted Average Shares Outstanding (Diluted)
11.87B 11.92B 11.95B 11.96B 11.96B
Currency in CNY

CSPC Pharmaceutical Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis